LORI REED: Open Payments
NPI 1811398001 · MARIETTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$37,694 in 175 payments from 20 companies in 2025. Trend: 2023 $21,377 · 2024 $34,987 · 2025 $37,694
Speaker / faculty: $21,204Travel & lodging: $7,052Consulting: $5,750Food & beverage: $3,637Education: $51
| Company | Payments | Amount |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. | 33 | $17,513 |
| United Therapeutics Corporation | 37 | $14,453 |
| Merck Sharp & Dohme LLC | 22 | $4,133 |
| AstraZeneca Pharmaceuticals LP | 8 | $236 |
| GlaxoSmithKline, LLC. | 21 | $192 |
| Insmed, Inc. | 9 | $177 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $150 |
| Grifols USA, LLC | 6 | $125 |
| Axsome Therapeutics, Inc. | 5 | $116 |
| Regeneron Healthcare Solutions, Inc. | 5 | $113 |
Products named: UPTRAVI, WINREVAIR, TYVASO, OPSUMIT, Arikayce, TEZSPIRE, FASENRA, DUPIXENT.
Industry payments across GA — which companies pay providers there.
